Under the terms of the agreement extension, Mentor retains exclusive distribution rights for Lysonix in the US and gains non-exclusive rights for certain foreign markets. Minimum purchase requirements apply to both the US and world markets and represent significant growth over the previous year.
The Lysonix 3000 ultrasound assisted liposuction system provides multiple benefits to both patient and physician versus other liposuction methods, including small incision sites, targeted fat removal, reduced bleeding, reduced bruising, and faster procedure time, claims Misonix.
Michael McManus, Jr, president and CEO of Misonix, said: “Misonix is quite pleased to continue our long-term association with Mentor, a major force in the aesthetic surgery market. We look forward to continuing our collaboration in growing the ultrasound assisted liposuction market while exploring other potential applications for this valuable surgical tool.”